{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:10:16Z","timestamp":1784286616662,"version":"3.55.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100020728","name":"Fundaci\u00f3n Gonzalo R\u00edo Arronte","doi-asserted-by":"publisher","award":["ICyT-PINV11-26"],"award-info":[{"award-number":["ICyT-PINV11-26"]}],"id":[{"id":"10.13039\/501100020728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020728","name":"Fundaci\u00f3n Gonzalo R\u00edo Arronte","doi-asserted-by":"publisher","award":["INP-2040"],"award-info":[{"award-number":["INP-2040"]}],"id":[{"id":"10.13039\/501100020728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020728","name":"Fundaci\u00f3n Gonzalo R\u00edo Arronte","doi-asserted-by":"publisher","award":["NIDA-1R01DA030715-01"],"award-info":[{"award-number":["NIDA-1R01DA030715-01"]}],"id":[{"id":"10.13039\/501100020728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020728","name":"Fundaci\u00f3n Gonzalo R\u00edo Arronte","doi-asserted-by":"publisher","award":["SEP-CONACYT-2009-I0003-106549"],"award-info":[{"award-number":["SEP-CONACYT-2009-I0003-106549"]}],"id":[{"id":"10.13039\/501100020728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejphar.2020.173718","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T02:03:36Z","timestamp":1604714616000},"page":"173718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effect of the morphine\/heroin vaccine on opioid and non-opioid drug-induced antinociception in mice"],"prefix":"10.1016","volume":"891","author":[{"given":"Susana Barbosa","family":"M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Matus-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Hern\u00e1ndez","family":"Miramontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Salazar-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173718_bib1","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ejphar.2020.173718_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.5.4.7556","article-title":"Vaccines against morphine\/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors","volume":"5","author":"Anton","year":"2009","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.ejphar.2020.173718_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0278-5846(03)00177-5","article-title":"Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders","volume":"28","author":"Baca","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2020.173718_bib4","doi-asserted-by":"crossref","first-page":"104817","DOI":"10.1016\/j.yhbeh.2020.104817","article-title":"Mirtazapine reduces the expression of cocaine-induced locomotor sensitization in male and female Wistar rats","volume":"125","author":"Barbosa-M\u00e9ndez","year":"2020","journal-title":"Horm. Behav."},{"key":"10.1016\/j.ejphar.2020.173718_bib5","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1021\/acs.molpharmaceut.8b00592","article-title":"Preclinical efficacy and characterization of candidate vaccines for treatment of opioid use disorders using clinically viable carrier proteins","volume":"15","author":"Baruffaldi","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejphar.2020.173718_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jnr.23963","article-title":"Sex differences, gender and addiction","volume":"95","author":"Becker","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2020.173718_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00003088-197601030-00004","article-title":"The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone","volume":"1","author":"Berkowitz","year":"1976","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2020.173718_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173718_bib10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/mp400631w","article-title":"Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy","volume":"11","author":"Bremer","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejphar.2020.173718_bib11","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting synthetic designer opioids: a conjugate vaccine ablates lethal doses of fentanyl class drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejphar.2020.173718_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pr.117.013904","article-title":"Conjugate vaccine immunotherapy for substance use disorder","volume":"69","author":"Bremer","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2020.173718_bib13","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1021\/jacs.7b03334","article-title":"Development of a clinically viable heroin vaccine","volume":"139","author":"Bremer","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2020.173718_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173718_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2011.06.023","article-title":"Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial","volume":"120","author":"De Fulio","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2020.173718_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/2046-4053-3-105","article-title":"The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol","volume":"3","author":"Dennis","year":"2014","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ejphar.2020.173718_bib17","first-page":"115","article-title":"Metabolism and disposition of prescription opioids: a review","volume":"27","author":"DePriest","year":"2015","journal-title":"Forensic Sci. Rev."},{"key":"10.1016\/j.ejphar.2020.173718_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.2042-7158.1969.tb08312.x","article-title":"The effect of narcotics and narcotic antagonists on the tail-flick response in spinal mice","volume":"21","author":"Dewey","year":"1969","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173718_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2165\/11205830-000000000-00000","article-title":"Tramadol\/paracetamol fixed-dose combination: a review of its use in the management of moderate to severe pain","volume":"30","author":"Dhillon","year":"2010","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.ejphar.2020.173718_bib20","first-page":"37","article-title":"Update on the clinical use of buprenorphine: in opioid-related disorders","volume":"58","author":"Ducharme","year":"2012","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ejphar.2020.173718_bib21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s12325-019-01201-3","article-title":"Sex-related differences in pharmacokinetics and pharmacodynamics of frequently prescribed drugs: a review of the literature","volume":"37","author":"Farkouh","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejphar.2020.173718_bib22","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1073\/pnas.1805268115","article-title":"Biological sex affects vaccine efficacy and protection against influenza in mice","volume":"115","author":"Fink","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173718_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2020.173718_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/03639045.2013.846365","article-title":"Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine\/naloxone tablet formulation in healthy volunteers","volume":"41","author":"Fischer","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"12","key":"10.1016\/j.ejphar.2020.173718_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-015-0058-x","article-title":"Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. Harm","volume":"6","author":"Green","year":"2015","journal-title":"Reduct. J."},{"key":"10.1016\/j.ejphar.2020.173718_bib26","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/acschemneuro.8b00079","article-title":"Efficacious vaccine against heroin contaminated with fentanyl","volume":"9","author":"Hwang","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173718_bib27","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1021\/acsomega.8b01478","article-title":"Improved admixture vaccine of fentanyl and heroin hapten immunoconjugates: antinociceptive evaluation of fentanyl-contaminated heroin","volume":"3","author":"Hwang","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejphar.2020.173718_bib28","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/acs.molpharmaceut.7b00933","article-title":"Enhancing efficacy and stability of an antiheroin vaccine: examination of antinociception, opioid binding profile, and lethality","volume":"15","author":"Hwang","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejphar.2020.173718_bib29","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1016\/j.vaccine.2019.05.061","article-title":"Heroin vaccine: using titer, affinity, and antinociception as metrics when examining sex and strain differences","volume":"37","author":"Hwang","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ejphar.2020.173718_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03007486","article-title":"Analgesia and serum concentrations of extradural, subdural and intraperitoneal fentanyl in a rat model","volume":"37","author":"Immelman","year":"1990","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.ejphar.2020.173718_bib31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1517\/14740338.2015.1037274","article-title":"Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review","volume":"14","author":"Kim","year":"2015","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2020.173718_bib32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jnr.23861","article-title":"Preclinical sex differences in depression and antidepressant response: implications for clinical research","volume":"95","author":"Kokras","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2020.173718_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pnpbp.2013.05.012","article-title":"A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats","volume":"45","author":"Kosten","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2020.173718_bib34","doi-asserted-by":"crossref","first-page":"9\u201015","DOI":"10.1093\/trstmh\/tru167","article-title":"Sex-based differences in immune function and responses to vaccination","volume":"109","author":"Klein","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejphar.2020.173718_bib35","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1471-4159.2011.07502.x","article-title":"A. morphine\/heroin vaccine with new hapten design attenuates behavioral effects in rats","volume":"119","author":"Li","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2020.173718_bib36","doi-asserted-by":"crossref","first-page":"pyu093","DOI":"10.1093\/ijnp\/pyu093","article-title":"A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats","volume":"18","author":"Li","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173718_bib37","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1213\/00000539-200009000-00034","article-title":"Gabapentin in pain management","volume":"91","author":"Mao","year":"2000","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2020.173718_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11916-006-0011-5","article-title":"Opioid-induced abnormal pain sensitivity","volume":"10","author":"Mao","year":"2006","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ejphar.2020.173718_bib39","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.vaccine.2014.01.028","article-title":"Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine","volume":"32","author":"Matyas","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ejphar.2020.173718_bib40","first-page":"93","article-title":"The utilization of opiates in pain management: use or abuse","volume":"49","author":"Mitra","year":"2013","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"10.1016\/j.ejphar.2020.173718_bib41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ogc.2014.02.005","article-title":"Buprenorphine and methadone for opioid addiction during pregnancy","volume":"41","author":"Mozurkewich","year":"2014","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.ejphar.2020.173718_bib42","doi-asserted-by":"crossref","first-page":"116926","DOI":"10.1016\/j.lfs.2019.116926","article-title":"Sex differences in pain and opioid mediated antinociception: modulatory role of gonadal hormones","volume":"237","author":"Nasser","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173718_bib43","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3762\/bjoc.15.100","article-title":"A chemically contiguous hapten approach for a heroin-fentanyl vaccine","volume":"15","author":"Natori","year":"2019","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejphar.2020.173718_bib44","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000542-197605000-00008","article-title":"Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action","volume":"44","author":"Ngai","year":"1976","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2020.173718_bib46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine\/naloxone: a review of its use in the treatment of opioid dependence","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2020.173718_bib47","first-page":"49","article-title":"Tolerance to opioid analgesics: clinical aspects","volume":"21","author":"Portenoy","year":"1994","journal-title":"Canc. Surv."},{"key":"10.1016\/j.ejphar.2020.173718_bib48","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.vaccine.2012.04.101","article-title":"Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats","volume":"30","author":"Pravetoni","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ejphar.2020.173718_bib49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.111.189506","article-title":"An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia","volume":"341","author":"Pravetoni","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173718_bib50","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/jm3013745","article-title":"Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens","volume":"56","author":"Pravetoni","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173718_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096547","article-title":"Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2020.173718_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101807","article-title":"Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2020.173718_bib53","doi-asserted-by":"crossref","first-page":"107662","DOI":"10.1016\/j.neuropharm.2019.06.001","article-title":"Development of vaccines to treat opioid use disorders and reduce incidence of overdose","volume":"158","author":"Pravetoni","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173718_bib54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173718_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115696","article-title":"Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats","volume":"9","author":"Raleigh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2020.173718_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2020.173718_bib57","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.117.247049","article-title":"Opioid dose- and route-dependent efficacy of oxycodone and heroin vaccines in rats","volume":"365","author":"Raleigh","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173718_bib58","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.118.253674","article-title":"A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats","volume":"368","author":"Raleigh","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173718_bib59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5114\/aoms.2014.42584","article-title":"Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial","volume":"10","author":"Sabzghabaee","year":"2014","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ejphar.2020.173718_bib60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.17711\/SM.0185-3325.2013.028","article-title":"Nuevas Vacunas contra la morfina\/hero\u00edna","volume":"36","author":"Salazar-Ju\u00e1rez","year":"2013","journal-title":"Salud Ment"},{"key":"10.1016\/j.ejphar.2020.173718_bib61","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2020.173718_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yhbeh.2009.12.003","article-title":"Estradiol: a key biological substrate mediating the response to cocaine in female rats","volume":"58","author":"Segarra","year":"2010","journal-title":"Horm. Behav."},{"key":"10.1016\/j.ejphar.2020.173718_bib63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0304-3959(97)00065-1","article-title":"Gabapentin enhances the antinociceptive effects of spinal morphine in the rat tail-flick test","volume":"72","author":"Shimoyama","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173718_bib65","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1073\/pnas.69.7.1835","article-title":"Coupling of a new, active morphine derivative to sepharose for affinity chromatography","volume":"69","author":"Simon","year":"1972","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2020.173718_bib66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-pharmtox-010617-052534","article-title":"The opioid epidemic: crisis and solutions","volume":"58","author":"Skolnick","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2020.173718_bib67","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/09540261.2018.1514369","article-title":"Comorbid chronic pain and opioid use disorder: literature review and potential treatment innovations","volume":"30","author":"Speed","year":"2018","journal-title":"Int. Rev. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173718_bib68","doi-asserted-by":"crossref","first-page":"584","DOI":"10.7326\/0003-4819-130-7-199904060-00019","article-title":"Acute heroin overdose","volume":"130","author":"Sporer","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2020.173718_bib69","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1021\/jm200461m","article-title":"A vaccine strategy that induces protective immunity against heroin","volume":"54","author":"Stowe","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173718_bib70","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/187152711799219316","article-title":"Developing a vaccine against multiple psychoactive targets: a case study of heroin","volume":"10","author":"Stowe","year":"2011","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejphar.2020.173718_bib71","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00004714-199602000-00010","article-title":"Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index","volume":"16","author":"Strain","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173718_bib72","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/jm9903702","article-title":"Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor","volume":"43","author":"Subramanian","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173718_bib73","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1345\/aph.1G276","article-title":"Role of buprenorphine in the management of heroin addiction","volume":"40","author":"Sung","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2020.173718_bib74","doi-asserted-by":"crossref","first-page":"107730","DOI":"10.1016\/j.neuropharm.2019.107730","article-title":"Vaccine blunts fentanyl potency in male rhesus monkeys","volume":"158","author":"Tenney","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2020.173718_bib75","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0022-3565(24)36562-0","article-title":"Characterization of neonatal rat fentanyl tolerance and dependence","volume":"281","author":"Thornton","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173718_bib76","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/s41386-019-0385-9","article-title":"Conjugate vaccine produces long-lasting attenuation of fentanyl vs.food choice and blocks expression of opioid withdrawal-induced increases infentanyl choice in rats","volume":"44","author":"Townsend","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2020.173718_bib77","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1021\/ar9001153","article-title":"Gabapentin: a stereochemically constrained gamma amino acid residue in hybrid peptide design","volume":"42","author":"Vasudev","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejphar.2020.173718_bib78","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1126\/science.178.4061.647-b","article-title":"The structure of morphine monohemisuccinate","volume":"178","author":"Wainer","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.173718_bib79","series-title":"Basic and Clinical Pharmacology","first-page":"512","article-title":"Opioid analgesics and antagonists","author":"Way","year":"2001"},{"key":"10.1016\/j.ejphar.2020.173718_bib80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/pm\/pnw344","article-title":"Human abuse potential of the new opioid analgesic molecule NKTR-181 compared with oxycodone","volume":"19","author":"Webster","year":"2018","journal-title":"Pain Med."},{"key":"10.1016\/j.ejphar.2020.173718_bib81","first-page":"470","article-title":"Gabapentin. Pfizer","volume":"3","author":"Wheeler","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2020.173718_bib82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: a review of evidence in both developed and developing worlds","volume":"3","author":"Whelan","year":"2012","journal-title":"J. Neurosci. Rural Pract."},{"key":"10.1016\/j.ejphar.2020.173718_bib83","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1248\/bpb.34.349","article-title":"Enhanced analgesic effects of propacetamol and tramadol combination in rats and mice","volume":"34","author":"Zhang","year":"2011","journal-title":"Biol. Pharm. Bull."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:43:59Z","timestamp":1757976239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920308104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":80,"alternative-id":["S0014299920308104"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173718","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the morphine\/heroin vaccine on opioid and non-opioid drug-induced antinociception in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173718"}}